Trademark Overview
On Wednesday, June 29, 2022, a trademark application was filed for TWELVE BIO with the United States Patent and Trademark Office. The USPTO has given the TWELVE BIO trademark a serial number of 79354964. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, December 20, 2023. This trademark is owned by Twelve Bio ApS. The TWELVE BIO trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceuticals and biological preparations based on gene, genome and cellular correction, editing, modification, modulation, engineering, regulation, repair and therapy for use in human therapeutics; gene therapy products for the treatment of genetic diseases and disorders; medical preparations; sanitary preparations for medical purposes; sanitary preparations for medical use; cells for medical and clinical use; chemical preparations for use in DNA analysis [medical]; stem cells
Scientific and medical research in the field of gene, genome and cellular correction, editing, modification, modulation, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations and diagnostic products and services; providing non-downloadable bioinformatic software for gene, genome and cellular correction, editing, modification, modulation, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations and diagnostic products and services; scientific study and research in the fields of gene, genome and cellular correction, editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations and diagnostic products and services; genetic engineering services; scientific and technological services; information, advisory and consultancy relating to the aforesaid services
